| Parameters | Total number of patients No. % | VEGF immunoexpression | P value | R test | |
| Positive No. % | Negative No. % | ||||
| Type of breast tissue |
|
|
| P < 0.05 | R > 0.3 |
| Normal | 20 (17.39) | 0 (0) | 20 (100) | ||
| Benign (fibroadenoma) | 20 (21.74) | 4 (20) | 16 (80) | ||
| Malignant | 52 (60.87) | 31 (59.62) | 21 (40.38) | ||
| Histological type |
|
|
| P < 0.05 |
|
| Lobular carcinomas | 8 (15.38) | 2 (25) | 6 (75) | ||
| Ductal carcinomas | 44 (84.62) | 29 (65.91) | 15 (34.09) | ||
| Including: |
|
|
| P < 0.05 | |
| Pure IDC | 29 (55.78) | 14 (48.28) | 15 (51.72) | ||
| IDC + DCIS | 8 (15.38) | 8 (100) | 0 (0) | ||
| IDC + Paget’s | 4 (7,69) | 4 (100) | 0 (0) | ||
| Pure DCIS | 3 (5.77) | 3 (100) | 0 (0) | ||
| Tumor grade |
|
|
| P > 0.05 | R > 0.3 |
| I | 2 (3.84) | 0 (0) | 2 (100) | ||
| II | 12 (23.08) | 6 (50) | 6 (50) | ||
| III | 38 (73.08) | 25 (65.79) | 13 (34.21) | ||
| Tumor size |
|
|
| P > 0.05 | R > 0.3 |
| Tis | 3 (5.77) | 3 (100) | 0 (0) | ||
| T1 (≤2 cm) | 6 (11.54) | 1 (16.67) | 5 (83.33) | ||
| T2 (2 > −5 cm) | 24 (46.15) | 14 (58.33) | 10 (41.67) | ||
| T3 (>5 cm) | 15 (28.85) | 9 (60) | 6 (40) | ||
| T4 (anyT+other) | 4 (7.69) | 4 (100) | 0 (0) | ||
| Axillary lymph nodes |
|
|
| P > 0.05 | R > 0.3 |
| Negative | 11 (30.56) | 5 (45.45) | 6 (54.55) | ||
| Positive | 25 (69.44) | 16 (64) | 9 (36) | ||
| Age of the patient |
|
|
| P > 0.05 |
|
| 21 - 30 years | 9 (17.31) | 6 (66.67) | 3 (33.33) | ||
| 31 - 40 years | 8 (15.38) | 6 (75) | 2 (25) | ||
| 41 - 50 years | 17 (32.69) | 12 (70.59) | 5 (29.41) | ||
| 51 - 60 years | 5 (9.62) | 2 (40) | 3 (60) | ||
| 61 - 70 years | 13 (25) | 5 (38.46) | 8 (61.54) | ||